Rahul Sharma (Editor)

Technetium (99mTc) votumumab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

ATC code
  
V09IA04 (WHO)

CAS Number
  
148189-70-2

Source
  
Human

Legal status
  
not marketed

Target
  
tumor antigen CTAA16.88

Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m. It was developed for the detection of colorectal tumors, but has never been marketed.

The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.

References

Technetium (99mTc) votumumab Wikipedia